下一个

自动播放

Jonathan Trent on Trabectedin for Soft Tissue Sarcoma

2 意见 • 07/18/23
分享
嵌入
administrator
administrator
订户
0

Jonathan Trent, MD, PhD, associate director for clinical research, director of the Sarcoma Medical Research Program at the Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, discusses the approval of trabectedin (Yondelis) to treat patients with soft tissue sarcoma.

显示更多
0 注释 sort 排序方式
脸书评论

下一个

自动播放